Table 6.

Pearson Product-Moment Correlations Between Observed Communication and Patient Self-Reports

	Observed Oncologist-Patient-Family/Companion Communication (Time 1)
Decision-Related Outcome (Time 2)	MD-PT Alliance	MD-FM/C Alliance	MD-PT Conversation Control	MD-PT-FM/C Conversation Control	No. of LIM	No. of AE	No. Trial Benefits Mentioned	Reassurance About Enrollment Status	AE-Related Support
Decision	0.06	0.03	0.28*	0.40‡	0.04	0.13	−0.19	0.03	0.13
Decision-related affect/cognition
Confidence in decision	0.15	0.27	0.40†	0.27	0.10	0.02	0.03	−0.10	0.22
Confidence in MD	0.16	0.22	0.42†	0.37*	0.14	−0.02	0.11	0.14	0.12
MD-PT-FM/C relationship quality	0.20	0.34	0.25	0.21	0.06	−0.03	−0.06	0.18	0.22
MD-PT-FM/C decision agreement	−0.01	0.15	0.40*	0.51†	0.11	−0.03	−.22	0.08	0.19
Reasons for decision
Personal	−0.08	−0.07	−0.01	0.26	0.09	−0.15	0.03	−0.05	0.07
MD communication	−0.12	0.02	−0.21	0.08	0.53‡	−0.09	0.38‡	0.23	0.18
Family opinions	−0.28	−0.49‡	−0.20	−0.37	0.04	−0.26	0.22	−0.27	0.01
Cost manageability	−0.58‡	−0.58‡	0.04	0.10	−.37*	−0.29	0.02	−0.46‡	−0.32*
AE manageable	0.26	0.04	−0.25	0.06	0.29	0.39‡	0.28	−0.49‡	0.42‡

Abbreviations: MD, oncologist; PT, patient; FM/C, family member/companion; LIM, legal/informational messages; AE, adverse effects messages.

^*P < .10.

^†P < .05.

^‡P < .01.